biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Jul 19, 2016 12:00pm

92 Views

Post# 25065348

RE:RE:RE:LOL! The price action here is predictable and should have

Jekyl Jr. Little baby boy.

Another shot at JD.

Oh my, I'm sorry, I see I hurt your feelings. Dredging up bad memories of mean kids in the 2nd grade. I didn't realize just how tramatic it was for you. Those little boy 'hurts' that just won't go away.

What if we all got together and bought you a whole case of apple juice boxes!

Would you be able to stop the sniffles and clear away those tears?

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports